Related Experiment Video
Updated: Aug 14, 2026
07:00
Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis
Published on: September 26, 2016
Bone marrow micrometastasis in breast cancer
S Ozbas1, H Dafydd, A D Purushotham
1Department of General Surgery, Adnan Menderes University, Aydin, Turkey.
The British Journal of Surgery
|February 21, 2003
Summary
Bone marrow micrometastasis in breast cancer patients is linked to higher recurrence and lower survival rates. Further research is needed to confirm its impact on survival and guide adjuvant therapy decisions.
Area of Science:
- Oncology
- Cancer Research
- Pathology
Background:
- Bone marrow micrometastasis is a significant indicator in breast cancer patients.
- Micrometastasis presence correlates with increased risk of systemic recurrence.
- It is also associated with poorer overall survival outcomes.
Purpose of the Study:
- To review the detection and clinical significance of bone marrow micrometastasis in breast cancer.
- To examine the relationship between micrometastasis and known prognostic factors.
- To evaluate the impact of micrometastasis on patient survival.
Main Methods:
- Comprehensive literature search of English language studies on bone marrow micrometastasis in breast cancer.
- Utilized Medline database (1975-2002) and cross-referenced key articles.
- Systematic review and synthesis of existing evidence.
Main Results:
- Evidence suggests bone marrow micrometastasis influences disease-free survival.
- The presence of micrometastasis appears to negatively impact overall survival.
- Correlation with established clinicopathological prognostic factors was examined.
Conclusions:
- The evidence supports the hypothesis that bone marrow micrometastasis affects survival outcomes.
- Further prospective studies are necessary for detailed evaluation.
- Investigate adjuvant systemic therapy efficacy in micrometastasis-positive patients, especially in early node-negative breast cancer.
